SCHEMBL17596092

SCHEMBL17596092

NCC(c1ccccc1)c1ncccc1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.50
HTR2A P28223 3/20 0.50
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
HRH1 P35367 2/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
AKT2 P31751 1/20 0.36
AKT1 P31749 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 1/20 0.35
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17596970 0.83 HTR2A (0.33) TAAR1HTR2AIDO1TDO2
SCHEMBL17596836 0.83 HTR2A (0.33) TAAR1HTR2AIDO1TDO2
Hydrochloric Acid SCHEMBL14484427 0.82 IDO1 (0.36) TAAR1HTR2AIDO1TDO2
SCHEMBL14784045 0.78 SLC6A2 (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3827602 0.77 SLC6A2 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29362942 0.77 SLC6A2 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14484409 0.74 TAAR1 (0.44) TAAR1HTR2ACHRNB2CHRNA4HRH1
SCHEMBL2316459 0.74 HTR2A (0.62) TAAR1HTR2ACHRNB2CHRNA4HRH1
SCHEMBL2066294 0.72 TAAR1 (0.60) TAAR1HTR2ACHRNB2CHRNA4HRH1
SCHEMBL17616528 0.71 EPHX1 (0.42) TAAR1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016040084-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2016-03-17 WO disclosed